S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

NYSEAMERICAN:MLSS - Milestone Scientific Stock Price, Forecast & News

$2.38
-0.10 (-4.03 %)
(As of 02/24/2020 04:00 PM ET)
Today's Range
$2.25
Now: $2.38
$2.46
50-Day Range N/A
52-Week Range
$0.31
Now: $2.38
$2.65
Volume417,100 shs
Average Volume422,542 shs
Market Capitalization$116.35 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MLSS
CUSIPN/A
Phone+1-973-5352717

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Market Cap$116.35 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.


Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) posted its earnings results on Wednesday, August, 14th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.02). The medical instruments supplier earned $2.26 million during the quarter. View Milestone Scientific's Earnings History.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Milestone Scientific.

What price target have analysts set for MLSS?

1 Wall Street analysts have issued 1-year target prices for Milestone Scientific's shares. Their forecasts range from $2.00 to $2.00. On average, they expect Milestone Scientific's share price to reach $2.00 in the next year. This suggests that the stock has a possible downside of 16.0%. View Analyst Price Targets for Milestone Scientific.

What is the consensus analysts' recommendation for Milestone Scientific?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Milestone Scientific.

Has Milestone Scientific been receiving favorable news coverage?

News headlines about MLSS stock have trended neutral on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Milestone Scientific earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Milestone Scientific.

Are investors shorting Milestone Scientific?

Milestone Scientific saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,790,000 shares, an increase of 62.7% from the December 31st total of 1,100,000 shares. Based on an average daily trading volume, of 501,700 shares, the short-interest ratio is presently 3.6 days. Currently, 6.6% of the company's shares are sold short. View Milestone Scientific's Current Options Chain.

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT), NovaBay Pharmaceuticals (NBY), Krystal Biotech (KRYS), Matinas BioPharma (MTNB), Cellectar Biosciences (CLRB), Viper Energy Partners (VNOM), Knowles (KN), Nokia Oyj (NOK), Osisko gold royalties (OR) and Bellicum Pharmaceuticals (BLCM).

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the folowing people:
  • Mr. Leonard A. Osser, Founder, Interim CEO & Director (Age 72)
  • Mr. Joseph D'Agostino CPA, CPA, CFO & COO (Age 67)
  • Ms. Sharon Smith, Exec. VP of Global Sales & Marketing
  • Mr. Gian Domenico Trombetta, Pres & CEO of Wand Dental Inc. and Director (Age 58)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

Who are Milestone Scientific's major shareholders?

Milestone Scientific's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include EAM Investors LLC (1.11%), Geode Capital Management LLC (0.28%) and Renaissance Technologies LLC (0.19%). Company insiders that own Milestone Scientific stock include Edward J Zelnick and Leonard Osser. View Institutional Ownership Trends for Milestone Scientific.

Which institutional investors are buying Milestone Scientific stock?

MLSS stock was purchased by a variety of institutional investors in the last quarter, including EAM Investors LLC, Renaissance Technologies LLC and Geode Capital Management LLC. Company insiders that have bought Milestone Scientific stock in the last two years include Edward J Zelnick and Leonard Osser. View Insider Buying and Selling for Milestone Scientific.

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $2.38.

How big of a company is Milestone Scientific?

Milestone Scientific has a market capitalization of $116.35 million. Milestone Scientific employs 16 workers across the globe.View Additional Information About Milestone Scientific.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is http://www.milesci.com/.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at +1-973-5352717.


MarketBeat Community Rating for Milestone Scientific (NYSEAMERICAN MLSS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  105 (Vote Underperform)
Total Votes:  206
MarketBeat's community ratings are surveys of what our community members think about Milestone Scientific and other stocks. Vote "Outperform" if you believe MLSS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLSS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel